We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Par Pharmaceutical Recalls Treprostinil Injection Due to Silicone Particulates
Par Pharmaceutical Recalls Treprostinil Injection Due to Silicone Particulates
Par Pharmaceutical, a subsidiary of Endo International, announced a voluntary recall of one lot of treprostinil injection 20mg/20mL due to the potential for the presence of silicone particulates in the product solution.